DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Lusher JM, Lee CA, Kessler CM, Bedrosian CL ; ReFacto Phase 3 Study Group.
The safety and efficacy of B-domain deleted recombinant factor VIII concentrate in patients with severe haemophilia A.
Haemophilia 2003;
9 (1) 38-49
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.